SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce Rosen who wrote (6464)5/5/1999 10:49:00 AM
From: BDR  Read Replies (1) of 7041
 
<<Secrecy is a common practice in the competitive world of business.>>

Secrecy is antithetical to marketing and marketing is what is going to be required if Vasomax is ever going to have a hope (issues of efficacy notwithstanding). The drug will have to be marketed to the prescribing physicians and it will have to be marketed to the public. The AUA annual meeting is an opportunity to market to the largest collection of urologists in one place at one time and press releases that come out of this meeting are reaching the public as news items in the daily papers and evening news. ZONA has nothing to say at this meeting. If you want to explain this fact by concocting a theory about some boneheaded plan to market Vasomax (Bob's "stealth marketing") be my guest.

Yes, there are many explanations for the events surrounding Vasomax but some explanations are far more likely than others to reflect reality.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext